We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bluebird Bio’s $2 Million Gene Therapy is Worth the Cost, ICER Says
Bluebird Bio’s $2 Million Gene Therapy is Worth the Cost, ICER Says
A $2.1 million gene therapy with the potential to cure beta-thalassemia, a lifelong blood disorder, is worth the price, according to the Institute for Clinical and Economic Review (ICER).